| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8221152 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Currently employed stereotactic body radiation therapy dose regimens can provide safe effective local therapy even for larger solitary NSCLC tumors (up to 5.7 cm in tumor diameter or 100 cm3 in tumor volume) but are associated with more nonlocal failures as well as poorer survival. These observations suggest these patients may benefit from more extensive staging or consideration of adjuvant therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Zishan MD, Mojgan MD, Andrea MD, MSc, Anthony MD, PhD, Andrew J. MD, Alexander MD, B.C. John MD, PhD,